rosiglitazone has been researched along with Hematoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiao, Y; Wang, F; Wang, L; Wu, G; Wu, J; Zhang, Y | 1 |
| Aronowski, J; Gonzales, N; Grotta, J; Zhao, X | 1 |
2 other study(ies) available for rosiglitazone and Hematoma
| Article | Year |
|---|---|
Rosiglitazone infusion therapy following minimally invasive surgery for intracerebral hemorrhage evacuation decreases matrix metalloproteinase-9 and blood-brain barrier disruption in rabbits.
Topics: Animals; Blood-Brain Barrier; Brain; Brain Injuries; Cerebral Hemorrhage; Disease Models, Animal; Hematoma; Hypoglycemic Agents; Infusions, Intraventricular; Male; Matrix Metalloproteinase 9; Minimally Invasive Surgical Procedures; Permeability; PPAR gamma; Rabbits; Random Allocation; Rosiglitazone; Thiazolidinediones | 2015 |
Hematoma resolution as a therapeutic target: the role of microglia/macrophages.
Topics: Animals; Apoptosis; Catalase; CD36 Antigens; Cerebral Hemorrhage; Disease Models, Animal; Erythrocytes; Hematoma; Humans; Macrophages; Mice; Microglia; Phagocytosis; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2009 |